Vasomedical Inc. Reports Financial Results for the Year Ended May, 31, 2011

WESTBURY, N.Y.--(BUSINESS WIRE)--Vasomedical, Inc. (“Vasomedical”) (OTC:VASO.PK), a leader in the manufacture and sale of devices for the non-invasive treatment and management of cardiovascular diseases as well as a leader in the sale of diagnostic imaging products, today reported financial results for the fiscal year ended May 31, 2011. These results include the operations of the Company’s equipment segment as well as its sales representation segment, conducted through its wholly-owned subsidiary Vaso Diagnostics d/b/a VasoHealthcare which represents GE Healthcare (“GEHC”) for the sale of select diagnostic imaging products on an exclusive basis to specific market segments in the 48 contiguous states of the United States.